日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

A qualitative examination of cognitive behavioral therapy strategies and health management content to reduce fear of cancer recurrence among breast cancer survivors: Results from the FoRtitude study

对认知行为疗法策略和健康管理内容在降低乳腺癌幸存者对癌症复发的恐惧方面的定性研究:来自FoRtitude研究的结果

Beeler, Dori M; Jeter, Elizabeth; Leitzelar, Brianna N; Price, Sarah N; Hall, Daniel L; Raper, Pamela J; Levine, Beverly J; Dunsmore, Victoria J; Tooze, Janet A; Duffecy, Jenna; Victorson, David; Gradishar, William; Saphner, Thomas; Smith, Mary Lou; Penedo, Frank; Mohr, David C; Cella, David; Wagner, Lynne I

Use of web-based decision support to improve informed choice for chemoprevention: a qualitative analysis of pre-implementation interviews (SWOG S1904)

利用网络决策支持改善化学预防的知情选择:实施前访谈的定性分析(SWOG S1904)

Michel, Alissa M; Yi, Haeseung; Amenta, Jacquelyn; Collins, Nicole; Vaynrub, Anna; Umakanth, Subiksha; Anderson, Garnet; Arnold, Katie; Law, Cynthia; Pruthi, Sandhya; Sandoval-Leon, Ana; Shirley, Rachel; Perdekamp, Maria Grosse; Colonna, Sarah; Krisher, Stacy; King, Tari; Yee, Lisa D; Ballinger, Tarah J; Braun-Inglis, Christa; Mangino, Debra A; Wisinski, Kari; DeYoung, Claudia A; Ross, Masey; Floyd, Justin; Kaster, Andrea; VanderWalde, Lindi; Saphner, Thomas J; Zarwan, Corrine; Lo, Shelly; Graham, Cathy; Conlin, Alison; Yost, Kathleen; Agnese, Doreen; Jernigan, Cheryl; Hershman, Dawn L; Neuhouser, Marian L; Arun, Banu; Crew, Katherine D; Kukafka, Rita

A randomized phase III double-blind placebo-controlled trial of first-line chemotherapy and trastuzumab with or without bevacizumab for patients with HER2/neu-positive metastatic breast cancer: a trial of the ECOG-ACRIN Cancer Research Group (E1105)

一项针对 HER2/neu 阳性转移性乳腺癌患者的一线化疗联合曲妥珠单抗(有或无贝伐珠单抗)的随机 III 期双盲安慰剂对照试验:ECOG-ACRIN 癌症研究组 (E1105) 的一项试验

Mezzanotte-Sharpe, Jessica; ONeill, Anne; Mayer, Ingrid A; Arteaga, Carlos L; Yang, Ximing J; Wagner, Lynne I; Cella, David; Meropol, Neal J; Alpaugh, R Katherine; Saphner, Thomas J; Swaney, Robert E; Hoelzer, Karen L; Gradishar, William J; Abramson, Vandana G; Sundaram, P Kothai; Jilani, Shamim Z; Perez, Edith A; Lin, Nancy U; Jahanzeb, Mohammad; Wolff, Antonio C; Sledge, George W; Reid, Sonya A

Making Informed Choices On Incorporating Chemoprevention into carE (MiCHOICE, SWOG 1904): Design and methods of a cluster randomized controlled trial

将化学预防纳入护理的知情选择(MiCHOICE,SWOG 1904):一项整群随机对照试验的设计和方法

Crew, K D; Anderson, G L; Arnold, K B; Stieb, A P; Amenta, J N; Collins, N; Law, C W; Pruthi, S; Sandoval-Leon, A; Bertoni, D; Grosse Perdekamp, M T; Colonna, S; Krisher, S; King, T; Yee, L D; Ballinger, T J; Braun-Inglis, C; Mangino, D; Wisinski, K B; DeYoung, C A; Ross, M; Floyd, J; Kaster, A; Vander Walde, L; Saphner, T; Zarwan, C; Lo, S; Graham, C; Conlin, A; Yost, K; Agnese, D; Jernigan, C; Hershman, D L; Neuhouser, M L; Arun, B; Kukafka, R

Clinical and Genomic Risk for Late Breast Cancer Recurrence and Survival

晚期乳腺癌复发和生存的临床和基因组风险

Sparano, Joseph A; Crager, Michael; Gray, Robert J; Tang, Gong; Hoag, Jess; Baehner, Frederick L; Shak, Steven; Makower, Della F; Albain, Kathy S; Hayes, Daniel F; Geyer, Charles E; Dees, Elizabeth C; Goetz, Matthew P; Olson, John A; Lively, Tracy; Badve, Sunil S; Saphner, Thomas J; Whelan, Timothy J; Kaklamani, Virginia G; Wolmark, Norman; Sledge, George W; Stemmer, Salomon M

A randomized phase III double-blind placebo-controlled trial of first line chemotherapy and trastuzumab with or without bevacizumab for patients with HER2/neu-positive metastatic breast cancer: a trial of the ECOG-ACRIN Cancer Research Group (E1105)

一项针对 HER2/neu 阳性转移性乳腺癌患者的一线化疗联合曲妥珠单抗(有或无贝伐珠单抗)的随机 III 期双盲安慰剂对照试验:ECOG-ACRIN 癌症研究组的一项试验 (E1105)

Mezzanotte-Sharpe, Jessica; ONeill, Anne; Mayer, Ingrid A; Arteaga, Carlos L; Yang, Ximing J; Wagner, Lynne I; Cella, David; Meropol, Neal J; Alpaugh, R Katherine; Saphner, Thomas J; Swaney, Robert E; Hoelzer, Karen L; Gradishar, William J; Abramson, Vandana G; Sundaram, P Kothai; Jilani, Shamim Z; Perez, Edith A; Lin, Nancy U; Jahanzeb, Mohammad; Wolff, Antonio C; Sledge, George W; Reid, Sonya A

Olanzapine With or Without Fosaprepitant for Preventing Chemotherapy Induced Nausea and Vomiting in Patients Receiving Highly Emetogenic Chemotherapy: A Phase III Randomized, Double-Blind, Placebo-Controlled Trial (ALLIANCE A221602)

奥氮平联合或不联合福沙匹坦预防接受高致吐性化疗患者化疗引起的恶心和呕吐:一项 III 期随机、双盲、安慰剂对照试验 (ALLIANCE A221602)

Navari, Rudolph M; Le-Rademacher, Jennifer; Smieliauskas, Fabrice; Ruddy, Kathryn J; James Saphner, Thomas; Liu, Heshan; Harlos, Elizabeth; Onitilo, Adedayo A; Giridhar, Karthik; Paul Singh, Preet; Reddy, Pavan S; Chow, Selina; Kruter, Flavio; Raptis, George; Loprinzi, Charles L

A spotlight on avoidance coping to manage fear of recurrence among breast cancer survivors in an eHealth intervention

一项电子健康干预措施重点关注乳腺癌幸存者为应对复发恐惧而采取的回避应对方式

Hall, Daniel L; Levine, Beverly J; Jeter, Elizabeth; Chandler, Allison; Tooze, Janet A; Duffecy, Jenna; Victorson, David; Gradishar, William; Leach, Joseph; Saphner, Thomas; Smith, Mary Lou; Penedo, Frank; Mohr, David C; Cella, David; Wagner, Lynne I

Race, Ethnicity, and Clinical Outcomes in Hormone Receptor-Positive, HER2-Negative, Node-Negative Breast Cancer in the Randomized TAILORx Trial

随机TAILORx试验中激素受体阳性、HER2阴性、淋巴结阴性乳腺癌患者的种族、民族和临床结果

Albain, Kathy S; Gray, Robert J; Makower, Della F; Faghih, Amir; Hayes, Daniel F; Geyer, Charles E; Dees, Elizabeth C; Goetz, Matthew P; Olson, John A; Lively, Tracy; Badve, Sunil S; Saphner, Thomas J; Wagner, Lynne I; Whelan, Timothy J; Ellis, Matthew J; Wood, William C; Keane, Maccon M; Gomez, Henry L; Reddy, Pavan S; Goggins, Timothy F; Mayer, Ingrid A; Brufsky, Adam M; Toppmeyer, Deborah L; Kaklamani, Virginia G; Berenberg, Jeffrey L; Abrams, Jeffrey; Sledge, George W; Sparano, Joseph A

Clinical trial participation assessed by age, sex, race, ethnicity, and socioeconomic status

临床试验参与情况按年龄、性别、种族、民族和社会经济地位进行评估

Saphner, Thomas; Marek, Andy; Homa, Jennifer K; Robinson, Lisa; Glandt, Neha